CEN Biotech Inc (CENBF)
0.0033
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
CEN Biotech Revenue (Quarterly): 0.0941M for March 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | 0.0941M |
December 31, 2022 | 0.3088M |
September 30, 2022 | 0.1359M |
June 30, 2022 | 0.5425M |
Date | Value |
---|---|
March 31, 2022 | 0.3403M |
December 31, 2021 | 0.3547M |
September 30, 2021 | 0.2722M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0941M
Minimum
Mar 2023
0.5425M
Maximum
Jun 2022
0.2926M
Average
0.3088M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
Rimrock Gold Corp | -- |
InMed Pharmaceuticals Inc | 1.240M |
Venus Concept Inc | 18.13M |
Juva Life Inc | 1.725M |
Lucy Scientific Discovery Inc | 0.0097M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -0.4009M |
Total Expenses (Quarterly) | 0.478M |
EPS Diluted (Quarterly) | -0.021 |
Profit Margin (Quarterly) | -426.2% |